LEVY Health, an innovator in reproductive health technology, announced it has raised $4.5 million led by San Francisco-based venture firm XYZ Venture Capital, with additional participation from Atlantic Labs and Possible Ventures.
This new funding will be used to integrate LEVY Health’s virtual care pathways, which reduce treatment time from years to weeks, with electronic medical record software. It will also fuel the company’s growth across women’s health and reproductive care, with solutions for fertility clinics, fertility benefit providers, laboratories, and biopharma companies.
Studies have shown that a large percentage of women are diagnosed with an endocrine disorder at least once in their lifetime, and a large percentage of individuals in the U.S. struggle with fertility problems. But the shortage of women’s healthcare providers and reproductive endocrinologists (REIs) leaves millions of patients facing long, excruciating wait times for diagnoses and treatment. LEVY Health bridges this gap by applying smart algorithms, enabling precision diagnostics and personalized treatment recommendations.
Created by three women in 2021, LEVY Health has developed clinical decision support based on medical guidelines, clinical studies, and lab data. And the company’s software combines health information with lab results, defining virtual care pathways for patients. Patients and providers benefit from dynamic medical history intake, automated lab orders and interpretation of results, patient triaging to lower and higher complexity treatments, patient education, and direct virtual care. And LEVY Health’s software supports 152 diagnoses and provides treatment recommendations in line with ASRM, ESHRE, and ACOG standards, ensuring accurate diagnoses in weeks instead of years.
Healthcare providers utilizing the software see a reduction in treatment timelines from an average of 145 days to just 45, with significantly less physician time required per patient. By automating many administrative tasks, LEVY Health’s platform enables providers to dedicate more of their time to patient care and treatment.
The company’s clients include industry leaders like fertility, family building, and women’s health benefits provider Progyny, US fertility clinic groups Boston IVF and Texas Fertility Center, the Mexican fertility group Fertilidad Integral, and the US-based egg donation agency Everie.
The company is now working on applications for fertility clinics, fertility benefit providers, laboratories, and biopharma companies.
KEY QUOTES:
“Our platform can be seen as a clinic’s highly educated, virtual care coordinator, completing patient’s fertility work-up and educating them about next steps. Physicians can choose at which point they’ll take over, and for those customers who don’t provide care themselves, we have an offering that helps them partner with providers across most US states. Either way, we enable providers to focus on treatment planning at the first consultation.”
“We started LEVY Health with a clear vision: to close the reproductive care gap and ensure that more women are accurately diagnosed in a timely manner, thereby lowering treatment costs and increasing their chances for a healthy pregnancy. This funding will allow us to access more verticals in women’s health and to build tailored solutions for women in different reproductive phases of their lives.”
-Caroline Mitterdorfer, Co-founder and CEO of LEVY Health
“LEVY Health is demonstrating to the entire healthcare market what is possible when you build solutions that help providers expedite the parts of their job that keep them from providing the standard of care they wish they could. This makes life better for everyone – providers can serve their patients better while unlocking new revenue models, and patients themselves no longer have to sit with uncertainty during crucial moments. I have conviction this is just the beginning of the change LEVY Health is going to make.”
-Ross Fubini, Founder & Managing Partner of XYZ Venture Capital
